Sylvia TrentAdams - AMN Healthcare Independent Director
| AMN Stock | USD 27.16 1.32 5.11% |
Insider
Sylvia TrentAdams is Independent Director of AMN Healthcare Services since 2020.
| Age | 55 |
| Tenure | 4 years |
| Address | 8840 Cypress Waters Boulevard, Dallas, TX, United States, 75019 |
| Phone | 866 871 8519 |
| Web | https://www.amnhealthcare.com |
AMN Healthcare Management Efficiency
The company has Return on Asset of 0.0315 % which means that on every $100 spent on assets, it made $0.0315 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0621 %, implying that it generated $0.0621 on every 100 dollars invested. AMN Healthcare's management efficiency ratios could be used to measure how well AMN Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, AMN Healthcare's Return On Tangible Assets are very stable compared to the past year. As of the 26th of November 2024, Return On Assets is likely to grow to 0.08, while Return On Capital Employed is likely to drop 0.1. At this time, AMN Healthcare's Intangibles To Total Assets are very stable compared to the past year. As of the 26th of November 2024, Return On Assets is likely to grow to 0.08, while Other Assets are likely to drop 0.95.Similar Executives
| Showing other executives | INSIDER Age | ||
| Kevin Connor | Encompass Health Corp | 53 | |
| Olivia Patton | InnovAge Holding Corp | N/A | |
| Derek Bunker | Pennant Group | 36 | |
| Pete Hartley | Amedisys | N/A | |
| Melanie Lewis | Encompass Health Corp | N/A | |
| Mark Miller | Encompass Health Corp | N/A | |
| Laurence Harrod | Acadia Healthcare | 67 | |
| Matthew Peterson | Universal Health Services | 54 | |
| Kendra Kimmons | Amedisys | N/A | |
| Joel Veit | Select Medical Holdings | N/A | |
| Mike Bavaro | Option Care Health | N/A | |
| Terrance Williams | Encompass Health Corp | 52 | |
| Rob Borella | InnovAge Holding Corp | N/A | |
| Jennifer Griffin | Amedisys | N/A | |
| Barbara CPA | InnovAge Holding Corp | 61 | |
| Maria Lozzano | InnovAge Holding Corp | 44 | |
| David CFA | Acadia Healthcare | N/A | |
| Anthony Hernandez | Encompass Health Corp | 58 | |
| Christopher Hunter | Acadia Healthcare | 56 | |
| Andrew Honeybone | Acadia Healthcare | N/A | |
| Adam Holton | Amedisys | 53 | |
Management Performance
| Return On Equity | 0.0621 | ||||
| Return On Asset | 0.0315 |
AMN Healthcare Services Leadership Team
Elected by the shareholders, the AMN Healthcare's board of directors comprises two types of representatives: AMN Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AMN. The board's role is to monitor AMN Healthcare's management team and ensure that shareholders' interests are well served. AMN Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AMN Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| R Harris, Independent Director | ||
| Cole Edmonson, Chief Experience and Clinical Officer | ||
| Nishan Sivathasan, Division Solutions | ||
| Mark Foletta, Independent Director | ||
| Landry Seedig, Group President and Chief Operating Officer, Nurse and Allied Solutions | ||
| Julie Fletcher, Chief Officer | ||
| Randle Reece, IR Contact Officer | ||
| Kelly Rakowski, Group President and Chief Operating Officer, Strategic Talent Solutions | ||
| Jeffrey Knudson, Chief Financial Officer, Chief Accounting Officer | ||
| Meredith Lapointe, Chief Officer | ||
| Patrick McCall, Chief Officer | ||
| Brian Scott, Chief Financial Officer, Chief Accounting Officer, Treasurer | ||
| Teri Fontenot, Independent Director | ||
| Whitney Laughlin, Corporate Officer | ||
| Christopher Schwartz, Principal Financial Officer | ||
| Denise Jackson, Senior Vice President, General Counsel, Secretary | ||
| Michael Johns, Independent Director | ||
| Julie Purinton, Division Nurse | ||
| Susan Salka, CEO and President Director and Member of Executive Committee | ||
| James Taylor, Group President and Chief Operating Officer for Physician & Leadership Solutions | ||
| Kimberly Martini, Division Solutions | ||
| Jorge Caballero, Independent Director | ||
| Martha Marsh, Independent Director | ||
| Mark Hagan, Chief Information Office and Digital Officer, Executive Officer | ||
| Robin Johnson, Group Solutions | ||
| Sylvia TrentAdams, Independent Director | ||
| Douglas Wheat, Independent Chairman of the Board | ||
| Caroline Grace, CEO President | ||
| Carolyn Kenny, Chief Officer | ||
| Jeff Decker, Division Solutions | ||
| Daphne Jones, Independent Director |
AMN Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AMN Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0621 | ||||
| Return On Asset | 0.0315 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 2.18 B | ||||
| Shares Outstanding | 38.07 M | ||||
| Shares Owned By Insiders | 0.75 % | ||||
| Shares Owned By Institutions | 99.25 % | ||||
| Number Of Shares Shorted | 4.2 M | ||||
| Price To Earning | 12.02 X |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMN Healthcare Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AMN Healthcare. If investors know AMN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AMN Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share 1.43 | Revenue Per Share 80.434 | Quarterly Revenue Growth (0.19) | Return On Assets 0.0315 |
The market value of AMN Healthcare Services is measured differently than its book value, which is the value of AMN that is recorded on the company's balance sheet. Investors also form their own opinion of AMN Healthcare's value that differs from its market value or its book value, called intrinsic value, which is AMN Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AMN Healthcare's market value can be influenced by many factors that don't directly affect AMN Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AMN Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if AMN Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AMN Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.